SOUTH SAN FRANCISCO, Calif. — TeraPore Technologies, the developer of advanced nanofiltration membrane systems for biomanufacturing, today announced it has raised $10M in new financing. The round was led by existing investor Anzu Partners with participation from Entegris (NASDAQ: ENTG), a global leader in advanced materials science, and fellow existing investor, RA Capital Management. TeraPore […]
Following record sales growth and launch of disruptive new product CEDAR PARK, TX — VUV Analytics, Inc. announced today that it has raised $20 million in equity financing—led by existing investors S3 Ventures and New Science Ventures—bringing its total funding to over $36 million. The announcement follows the recent launch of the company’s LUMA product […]
Investment marks Denmark’s largest seed round, funding an integrated hardware and software platform to accelerate discovery, reduce errors and eliminate cumbersome manual experimentation COPENHAGEN, Denmark — Reshape Biotech, an integrated hardware and software platform digitizing microbiology experiments, today announced an $8.1 million investment, Denmark’s largest-ever seed round. The oversubscribed investment was led by ACME Capital, with […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale CAMBRIDGE, England — EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 […]
Developing synthetic cells for a range of applications in diagnostics and therapeutics EMERYVILLE, Calif. — Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics, today announced the closing of $11 million in a Series A3 financing. The investment was co-led by ARCH Venture Partners and Northpond Ventures, […]
Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale testing in low to middle-income countries Bedfordshire, UK: MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP™ technology, has today announced it has secured a significant grant of funds from the Bill […]
The successful development of the measurement technology specialist from Graz continues: On the one hand, new subsidiaries were founded in the Netherlands and in the Philippines, on the other hand, Anton Paar was also able to achieve a turnover of more than half a billion euros for the first time in the company’s history. With […]
New partnerships will drive the commercial expansion of InDevR’s game-changing solutions for vaccines and biotherapeutics Boulder, CO — InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant Capital has invested $4 million, and bioMérieux – a worldwide leader in in vitro diagnostics […]
LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions in China Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech’s go-to-market strategy SHANGHAI — Shanghai LePure Biotech Co., Ltd. (“LePure” or “LePure Biotech”) announced the completion of its Series C financing from a consortium of world-renowned investors […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
